Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators. | Biomedicines | 2023 | 36672685 | PubTator, text mining | PubMed |
| Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens. | Contraception | 2023 | 36641094 | PubTator, text mining | PubMed |
| Pharmacogenetics of anxiety and depression in Alzheimer's disease. | Pharmacogenomics | 2023 | 36628952 | PubTator, text mining | PubMed |
| High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. | Antimicrob Agents Chemother | 2023 | 36622148 | PubTator, text mining | PubMed |
| Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis. | Clin Infect Dis | 2023 | 36609692 | PubTator, text mining | PubMed |
| Evaluation of nanoplastics toxicity to the human placenta in systems. | J Hazard Mater | 2023 | 36584646 | PubTator, text mining | PubMed |
| Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury. | Mol Biol Rep | 2023 | 36562936 | PubTator, text mining | PubMed |
| New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians. | Respiration | 2023 | 36516792 | PubTator, text mining | PubMed |
| Isoniazid pharmacokinetics/pharmacodynamics as monotherapy and in combination regimen in the hollow fiber system model of Mycobacterium kansasii. | Tuberculosis (Edinb) | 2023 | 36512853 | PubTator, text mining | PubMed |
| Accuracy of Rapid Emergency Medicine Score and Sequential Organ Failure Assessment Score in predicting acute paraphenylenediamine poisoning adverse outcomes. | Environ Sci Pollut Res Int | 2023 | 36462082 | PubTator, text mining | PubMed |
| Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis. | Digestion | 2023 | 36366816 | PubTator, text mining | PubMed |
| Expression pattern of secretory-cell-related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomes. | Mol Oncol | 2023 | 36349418 | PubTator, text mining | PubMed |
| Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study. | Diabetologia | 2023 | 36346460 | PubTator, text mining | PubMed |
| Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis. | Eur Respir J | 2023 | 36328357 | PubTator, text mining | PubMed |
| Cigarette Smoking, Smoking Cessation, and Bladder Cancer Risk: A Pooled Analysis of 10 Cohort Studies in Japan. | J Epidemiol | 2023 | 36310059 | PubTator, text mining | PubMed |
| Very important pharmacogenes polymorphism landscape and potential clinical relevance in the Chinese Mongolian. | Gene | 2023 | 36220448 | PubTator, text mining | PubMed |
| Genetics of drug-induced liver injury: Current knowledge and future prospects. | Clin Transl Sci | 2023 | 36194091 | PubTator, text mining | PubMed |
| Pharmacogenetic profiling via genome sequencing in children with medical complexity. | Pediatr Res | 2023 | 36167815 | PubTator, text mining | PubMed |
| N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances. | Arch Toxicol | 2023 | 36138126 | PubTator, text mining | PubMed |
| Upregulation of KAT2B and ESCO2 gene expression level in patients with rheumatoid arthritis. | Clin Rheumatol | 2023 | 36104638 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=16